JZL Tablet
Natural health product licensed in Canada
- Other names
- Jiang Zhi Ling Tablet
- Licence holder
- Lux Nutrition Inc.
- NPN or DIN-HM
- 80040598
- Status
- Active licence
- Licence date
- 7 March 2013
- Revision date
- Not provided
- Form
- Comprimé, enrobé par pellicule
- Route of administration
- Orale
- Application type
- Traditionnelle
If this product were sold in France
- Conditions légales
Senna obtusifolia (L.) H.S.Irwin & Barneby: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants de moins de 12 ans, aux femmes enceintes et allaitantes et une mention déconseillant l'usage prolongé.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Senna obtusifolia Source : Graine(s) Extract : Extract Type TBA Extraction ratio : 10:1 Dry plant equivalent : 44 mg | 4.4 mg | Not calculated |
| Lycium barbarum Source : Fruit Extraction ratio : 10:1 Dry plant equivalent : 222 mg | 22.2 mg | Not calculated |
| Reynoutria multiflora Source : Racine Extraction ratio : 10:1 Dry plant equivalent : 222 mg | 22.2 mg | Not calculated |
| Polygonatum cirrhifolium Source : Rhizome Extraction ratio : 10:1 Dry plant equivalent : 296 mg | 29.6 mg | Not calculated |
| Crataegus pinnatifida Source : Fruit Extract : Extract Type TBA Extraction ratio : 10:1 Dry plant equivalent : 148 mg | 14.8 mg | Not calculated |
| Crataegus pinnatifida Source : Fruit | Not specified | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Cellulose microcristalline, Croscarmellose de sodium, Dioxyde de titane
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 5 Comprimé | 3 days |
Uses authorised in Canada
Traditionally used in Chinese medicine to tonify the liver and the kidney, and to nourish the blood.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
N/A.
Source
Official Health Canada record, licence 80040598
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.